Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Robledo, Cristina ^a   García, Juan L ^a,b   Benito, Rocío ^a   Flores, Teresa ^c   Mollejo, Manuela ^d   Martínez Climent, José Ángel ^e   García, Eva ^f   Gutiérrez, Norma C ^c   Piris, Miguel A ^g   Hernández, Jesús M ^a,c  

^a CSIC   (Spain)

^b Instituto de Estudios de Ciencias de La Salud de Castilla y Leon   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL VIRGEN DE LA SALUD   (Spain)

^e UNIVERSITY OF NAVARRA   (Spain)

^f UNIVERSITY OF SALAMANCA   (Spain)

^g Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; SPLENIC MARGINAL ZONE LYMPHOMA; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME 7; CHROMOSOME DELETION; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; MARGINAL ZONE LYMPHOMA; MIDDLE AGED; REPRODUCIBILITY; SPLEEN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 7; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; SPLENIC NEOPLASMS;

EID: 80053034585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024939     Document Type: Article

References (56)

1. Schmid C, Kirkham N, Diss T, Isaacson PG, (1992) Splenic marginal zone cell lymphoma. Am J Surg Pathol 16: 455-466.
2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, et al. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361-1392.
3. Jaffe ES, Harris NL, Stein H, Isaacson PG, (2008) Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 112: 4384-4399.
4. Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, et al. (2008) Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 22: 487-495.
5. Hernandez JM, Garcia JL, Gutierrez NC, Mollejo M, Martinez-Climent JA, et al. (2001) Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics. Am J Pathol 158: 1843-1850.
6. Sole F, Salido M, Espinet B, Garcia JL, Martinez Climent JA, et al. (2001) Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Haematologica 86: 71-77.
7. Oscier DG, Matutes E, Gardiner A, Glide S, Mould S, et al. (1993) Cytogenetic studies in splenic lymphoma with villous lymphocytes. Br J Haematol 85: 487-491.
8. Troussard X, Mauvieux L, Radford-Weiss I, Rack K, Valensi F, et al. (1998) Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Francais d'Hematologie Cellulaire (GFHC) study. Br J Haematol 101: 712-721.
9. Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D, (2001) p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood 97: 3552-3558.
10. Callet-Bauchu E, Baseggio L, Felman P, Traverse-Glehen A, Berger F, et al. (2005) Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases. Leukemia 19: 1818-1823.
11. Gazzo S, Baseggio L, Coignet L, Poncet C, Morel D, et al. (2003) Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma. Haematologica 88: 31-38.
12. Salido M, Baro C, Oscier D, Stamatopoulos K, Dierlamm J, et al. (2010) Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood 116: 1479-88.
13. Andersen CL, Gruszka-Westwood A, Atkinson S, Matutes E, Catovsky D, et al. (2005) Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization. Cancer Genet Cytogenet 156: 122-128.
14. Dierlamm J, Rosenberg C, Stul M, Pittaluga S, Wlodarska I, et al. (1997) Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia 11: 747-758.
15. Andersen CL, Gruszka-Westwood A, Ostergaard M, Koch J, Jacobsen E, et al. (2004) A narrow deletion of 7q is common to HCL, and SMZL, but not CLL. Eur J Haematol 72: 390-402.
16. Matteucci C, Galieni P, Leoncini L, Lazzi S, Lauria F, et al. (2003) Typical genomic imbalances in primary MALT lymphoma of the orbit. J Pathol 200: 656-660.
17. Mateo M, Mollejo M, Villuendas R, Algara P, Sanchez-Beato M, et al. (1999) 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 154: 1583-1589.
18. Vega F, Cho-Vega JH, Lennon PA, Luthra MG, Bailey J, et al. (2008) Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes. Br J Haematol 142: 216-226.
19. Ferreira BI, Garcia JF, Suela J, Mollejo M, Camacho FI, et al. (2008) Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica 93: 670-679.
20. Watkins AJ, Huang Y, Ye H, Chanudet E, Johnson N, et al. (2010) Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis. J Pathol 220: 461-474.
21. Novara F, Arcaini L, Merli M, Passamonti F, Zibellini S, et al. (2009) High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma. Hum Pathol 40: 1628-1637.
22. Zeng WR, Scherer SW, Koutsilieris M, Huizenga JJ, Filteau F, et al. (1997) Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas. Oncogene 14: 2355-2365.
23. Zeng WR, Watson P, Lin J, Jothy S, Lidereau R, et al. (1999) Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene. Oncogene 18: 2015-2021.
24. Oscier DG, Gardiner A, Mould S, (1996) Structural abnormalities of chromosome 7q in chronic lymphoproliferative disorders. Cancer Genet Cytogenet 92: 24-27.
25. Sole F, Woessner S, Florensa L, Espinet B, Mollejo M, et al. (1997) Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma. Br J Haematol 98: 446-449.
26. Algara P, Mateo MS, Sanchez-Beato M, Mollejo M, Navas IC, et al. (2002) Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 99: 1299-1304.
27. Boonstra R, Bosga-Bouwer A, van Imhoff GW, Krause V, Palmer M, et al. (2003) Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32. Mod Pathol 16: 1210-1217.
28. Camacho FI, Mollejo M, Mateo MS, Algara P, Navas C, et al. (2001) Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Am J Surg Pathol 25: 1268-1276.
29. Chacon JI, Mollejo M, Munoz E, Algara P, Mateo M, et al. (2002) Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 100: 1648-1654.
30. Kufe DW, (2009) Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9: 874-885.
31. Duraisamy S, Ramasamy S, Kharbanda S, Kufe D, (2006) Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 and MUC16. Gene 373: 28-34.
32. Martinez-Climent JA, Alizadeh AA, Segraves R, Blesa D, Rubio-Moscardo F, et al. (2003) Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 101: 3109-3117.
33. Sinclair AM, Lee JA, Goldstein A, Xing D, Liu S, et al. (2001) Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice. Blood 98: 3658-3667.
34. Ueda Y, Su Y, Richmond A, (2007) CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells. Melanoma Res 17: 91-103.
35. Neville PJ, Thomas N, Campbell IG, (2001) Loss of heterozygosity at 7q22 and mutation analysis of the CDP gene in human epithelial ovarian tumors. Int J Cancer 91: 345-349.
36. Narahari J, Fisk JC, Melendy T, Roman A, (2006) Interactions of the cellular CCAAT displacement protein and human papillomavirus E2 protein with the viral origin of replication can regulate DNA replication. Virology 350: 302-311.
37. Sato K, Takeuchi T, Kukimoto I, Mori S, Yasugi T, et al. (2007) Human papillomavirus type 16 P670 promoter is negatively regulated by CCAAT displacement protein. Virus Genes 35: 473-481.
38. Michl P, Ramjaun AR, Pardo OE, Warne PH, Wagner M, et al. (2005) CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell 7: 521-532.
39. Michl P, Knobel B, Downward J, (2006) CUTL1 is phosphorylated by protein kinase A, modulating its effects on cell proliferation and motility. J Biol Chem 281: 15138-15144.
40. Ripka S, Konig A, Buchholz M, Wagner M, Sipos B, et al. (2007) WNT5A-target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28: 1178-1187.
41. Pal S, Baiocchi RA, Byrd JC, Grever MR, Jacob ST, et al. (2007) Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO J 26: 3558-3569.
42. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, et al. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835-3849.
43. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, et al. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4a Edition Volume 2.
44. Bredel M, Bredel C, Juric D, Kim Y, Vogel H, et al. (2005) Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA. J Mol Diagn 7: 171-182.
45. Robledo C, Garcia JL, Caballero D, Conde E, Arranz R, et al. (2009) Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas. Cancer 115: 3728-3737.
46. Herrero J, Al-Shahrour F, az-Uriarte R, Mateos A, Vaquerizas JM, et al. (2003) GEPAS: A web-based resource for microarray gene expression data analysis. Nucleic Acids Res 31: 3461-3467.
47. Montaner D, Tarraga J, Huerta-Cepas J, Burguet J, Vaquerizas JM, et al. (2006) Next station in microarray data analysis: GEPAS. Nucleic Acids Res 34: W486-W491.
48. Conde L, Montaner D, Burguet-Castell J, Tarraga J, Medina I, et al. (2007) ISACGH: a web-based environment for the analysis of Array CGH and gene expression which includes functional profiling. Nucleic Acids Res 35: W81-W85.
49. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, et al. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23: 41-46.
50. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al. (2004) Large-scale copy number polymorphism in the human genome. Science 305: 525-528.
51. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al. (2004) Detection of large-scale variation in the human genome. Nat Genet 36: 949-951.
52. Baumbusch LO, Aaroe J, Johansen FE, Hicks J, Sun H, et al. (2008) Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors. BMC Genomics 9: 379.
53. Selzer RR, Richmond TA, Pofahl NJ, Green RD, Eis PS, et al. (2005) Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44: 305-319.
54. Gonzalez MB, Hernandez JM, Garcia JL, Lumbreras E, Castellanos M, et al. (2004) The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma. Haematologica 89: 1213-1218.
55. Singh-Gasson S, Green RD, Yue Y, Nelson C, Blattner F, et al. (1999) Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array. Nat Biotechnol 17: 974-978.
56. Nuwaysir EF, Huang W, Albert TJ, Singh J, Nuwaysir K, et al. (2002) Gene expression analysis using oligonucleotide arrays produced by maskless photolithography. Genome Res 12: 1749-1755.